Amgen turned in a strong second quarter — but analysts say things are looking bleak

Behind second-quarter profit and earnings beats is a company that’s coasting, analysts say
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.